These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2207219

  • 1. Clomipramine in obsessive-compulsive disorder.
    Katz RJ, DeVeaugh-Geiss J, Landau P.
    Biol Psychiatry; 1990 Sep 01; 28(5):401-14. PubMed ID: 2207219
    [Abstract] [Full Text] [Related]

  • 2. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan 01; 31(1):45-9. PubMed ID: 1537780
    [Abstract] [Full Text] [Related]

  • 3. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug 01; 48(8):730-8. PubMed ID: 1883256
    [Abstract] [Full Text] [Related]

  • 4. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
    Berman I, Sapers BL, Chang HH, Losonczy MF, Schmildler J, Green AI.
    J Clin Psychopharmacol; 1995 Jun 01; 15(3):206-10. PubMed ID: 7635998
    [Abstract] [Full Text] [Related]

  • 5. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT, Hill JL, Murphy DL.
    Psychopharmacol Bull; 1990 Jun 01; 26(2):211-4. PubMed ID: 2236458
    [Abstract] [Full Text] [Related]

  • 6. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Jun 01; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul 01; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL.
    Am J Psychiatry; 1988 Dec 01; 145(12):1521-5. PubMed ID: 3057923
    [Abstract] [Full Text] [Related]

  • 11. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
    Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, Rapoport JL.
    Arch Gen Psychiatry; 1991 Oct 01; 48(10):922-7. PubMed ID: 1929762
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1992 Feb 01; 12(1):11-8. PubMed ID: 1552034
    [Abstract] [Full Text] [Related]

  • 14. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J, Landau P, Katz R.
    Psychopharmacol Bull; 1989 Feb 01; 25(1):36-40. PubMed ID: 2672070
    [Abstract] [Full Text] [Related]

  • 15. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.
    Arch Gen Psychiatry; 1990 Oct 01; 47(10):926-32. PubMed ID: 2222131
    [Abstract] [Full Text] [Related]

  • 16. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J, Judge R.
    Br J Psychiatry; 1996 Oct 01; 169(4):468-74. PubMed ID: 8894198
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J, Neziroglu F, Yaryura-Tobias JA.
    Psychiatry Res; 1985 Jan 01; 14(1):85-93. PubMed ID: 3887445
    [Abstract] [Full Text] [Related]

  • 19. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L.
    Arch Gen Psychiatry; 1980 Nov 01; 37(11):1281-5. PubMed ID: 7436690
    [Abstract] [Full Text] [Related]

  • 20. The antiobsessional effects of clomipramine do not require concomitant affective disorder.
    Katz RJ, DeVeaugh-Geiss J.
    Psychiatry Res; 1990 Feb 01; 31(2):121-9. PubMed ID: 2183254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.